Shares of Walgreens Boots Alliance, Inc. (CMG) traded 0.82 million shares at hands. (NYSE:JCP) by 3.48% during the September 2017 quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission.
Several other hedge funds also recently added to or reduced their stakes in the company. Burgundy Asset Management Ltd. raised its position in shares of Walgreens Boots Alliance by 0.6% during the 3rd quarter. Howe & Rusling Inc. now owns 1,441 shares of the pharmacy operator's stock worth $120,000 after buying an additional 975 shares during the period. AXA lifted its position in shares of Walgreens Boots Alliance by 12.4% in the 3rd quarter. Comparatively, WBA is expected to grow at a 15.40% annual rate. Schwab Charles Investment Management Inc. increased its holdings in shares of Walgreens Boots Alliance by 5.4% during the 2nd quarter. Hanson McClain Inc. now owns 1,987 shares of the pharmacy operator's stock valued at $156,000 after buying an additional 87 shares during the last quarter. IHT Wealth Management LLC increased its holdings in shares of Walgreens Boots Alliance by 46.3% during the second quarter. The institutional investor owned 251,710 shares of the pharmacy operator's stock after selling 761,843 shares during the quarter. Here we perceived that this stock is unhealthy for investors as it is getting smaller in last half year duration. In this case, shares are down -17.33%, the 52-week high touched on August 15, 2017, and are keeping their losses at 18.74% for the past 12 months. The formula for calculating the price-earnings ratio for any stock is simple: the market value per share divided by the earnings per share (EPS). The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.
Analyst notified mean rating at 2.20 after consensus analysis. While 20-Day Moving Average VS Current Price shows "Sell" Signal. Following the completion of the sale, the director now owns 16,415 shares in the company, valued at approximately $1,105,878.55. The disclosure for this purchase can be found here. The 14-day ADX for Walgreens Boots Alliance (WBA) presently sits at 25.33. The company has a market cap of $69,503.16, a P/E ratio of 13.76, a price-to-earnings-growth ratio of 1.25 and a beta of 1.22. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.07 and a quick ratio of 0.59. (NASDAQ:WBA) to report earnings on January, 4. The pharmacy operator reported $1.31 earnings per share for the quarter, beating the Zacks' consensus estimate of $1.21 by $0.10.
Looking at some ROIC (Return on Invested Capital) numbers, Walgreens Boots Alliance, Inc. During the same quarter in the previous year, the firm posted $1.07 earnings per share. The shares price go down so far this year; showing a decline of -14.15% and dropped with negative flow of -1.21% during recent week. The Company kept a record of 863.83 million floated shares and 997.89 million shares outstanding. NasdaqGS:WBA is 2.548570. A lower price to book ratio indicates that the stock might be undervalued.
The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 12th. This represents a $1.50 dividend on an annualized basis and a yield of 1.81%. Walgreens Boots Alliance's dividend payout ratio is 42.33%. (NASDAQ:WBA) on Thursday, October 29 with "Buy" rating. Vetr downgraded shares of Walgreens Boots Alliance from a "strong-buy" rating to a "buy" rating in a report on Friday, December 1st. The objective of using RSI is to help the trader identify over sold and overbought price areas. Deutsche Bank assumed coverage on Walgreens Boots Alliance in a research note on Monday. This is something that Investors should look for in all the stocks they are trading and is an important indicator to keep tabs on.
The average investment recommendation on a scale of 1 to 5 (1 being a strong buy, 3 a hold, and 5 a sell) is 2.90 for RAD and 2.20 for WBA, which implies that analysts are more bullish on the outlook for RAD.
The collective rating of 2.2 for Walgreens Boots Alliance, Inc.
Sinopharm said it would work with Walgreens Boots Alliance to explore opportunities in the broader Asian and global markets, in keeping with Beijing's Belt and Road Initiative. If you are viewing this article on another publication, it was illegally stolen and reposted in violation of United States & worldwide trademark and copyright legislation.